February 11, 2008 – A new minimally invasive vascular occlusion device designed to close a patent ductus arteriosus (PDA) received European CE Mark approval.
Toshiba’s Cardio Prospective helps reduce patient radiation dose by up to 80 percent during coronary CTA exams by using a helical acquisition technique to provide one continuous image instead of multiple images produced by the current step-and-shoot technique.
February 11, 2008 - The first patient has enrolled in the PROENCY (PROMUS, Endeavor and Cypher) European registry ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 11, 2008 - The American Society of Echocardiography (ASE) has issued a new consensus statement for interpreting ...
The Artida is reportedly the first ultrasound system with the ability to track and display myocardial motion and 3D volumes in 3D images. Two and 3D wall motion tracking features allow the user to obtain angle-independent, quantitative and regional information about myocardial contraction.
February 11, 2008 - Boston Scientific Corp. today announced that the first patient has been enrolled in its PROENCY ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Toshiba's Vantage Titan MRI is designed to capture higher resolution heart images, while capturing deeper imaging of the anatomy. This is possible due to the center eight elements of the cardiac coils being smaller and the outer eight elements of the cardiac coils being larger on the Vantage Titan according to Toshiba.
February 11, 2008 - The first patient was successfully treated in AtriCure’s ABLATE clinical trial designed to evaluate ...
February 11, 2008 - Battlefield Imaging of Ringgold, GA, has become the first facility in the U.S. to install the MAGNETOM ESSENZA magnetic resonance imaging (MRI) system from Siemens Healthcare, designed to be an affordable 1.5 Tesla system.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 11, 2008 - Leman Cardiovascular’s animal studies to evaluate the performance in both the aortic and mitral ...
A third round of software enhancements has been made to the iLab System 1.3, an ultrasound imaging system designed to strengthen physician confidence in the diagnosis and intervention of percutaneous coronary intervention (PCI) and increase workflow efficiency.
February 11, 2008 – Medrad Inc. today said it entered into a definitive merger agreement to acquire Possis Medical Inc., which in combination will offer a broader, more comprehensive suite of products to the cardiovascular intervention field.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 8, 2008 - Emageon received first place in the “Best in KLAS” Top 20 Report for the Cardiology PACS nomination ...
CryoLife Inc.'s CryoValve SG pulmonary human heart valve is processed with the company’s proprietary SynerGraft technology, providing a valve replacement option for children born with heart defects or for replacement surgery.
February 7, 2008 - Volcano Corp. said the FDA cleared the s5-Revo and s5-FFR (fractional flow reserve) options, enabling ...